Role of Serum Total Antioxidant Level in Preterm Labor
the Role of Serum Total Antioxidant Level in Preterm Labor
1 other identifier
observational
70
1 country
1
Brief Summary
The aim of this study is to detect the association between maternal serum antioxidant level and preterm labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 24, 2012
CompletedFirst Posted
Study publicly available on registry
January 26, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedJanuary 30, 2012
January 1, 2012
6 months
January 24, 2012
January 26, 2012
Conditions
Keywords
Study Arms (2)
preterm labor cases
Group A: 35 pregnant women diagnosed with preterm labor(Preterm labor pain at least 3 contraction every 20 minutes ,cervical dilatation \< 2cm and effacement\< 50%) which will deliver within one week maximum after hospitalization.
control group
Group B: 35 pregnant women( controls )with uncomplicated pregnancies at a similar gestational ages followed routinely in the antenatal care unit.
Eligibility Criteria
pregnant women attending the outpatient obstetric clinic and inpatient of Obstetrics and Gynecology department or when they will be admitted to the delivary room of Ain Shams university hospital.
You may qualify if:
- Preterm labor(pregnant between 28th and 37th week).
- Singleton pregnancy.
- Amnion membranes were intact
You may not qualify if:
- Past history of preterm labor or premature delivery.
- Urinary tract infections and any other infections.
- Poly- or oligohydramnios.
- Fetal distress, fetal or uterine anomaly.
- Membranes rupture and placenta pathology.
- Preeclampsia or intrauterine growth retardation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams Maternity Hospital
Cairo, Tertiary, Egypt
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ABDALLAH s ABDELATIF, residant
Ain Shams Maternity Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- THE ROLE OF SERUM TOTAL ANTI OXIDANT IN PRETERM LABOR
Study Record Dates
First Submitted
January 24, 2012
First Posted
January 26, 2012
Study Start
October 1, 2011
Primary Completion
April 1, 2012
Study Completion
May 1, 2012
Last Updated
January 30, 2012
Record last verified: 2012-01